Macrogen, Inc. (KOSDAQ:038290)
South Korea flag South Korea · Delayed Price · Currency is KRW
18,670
+610 (3.38%)
Feb 19, 2026, 3:10 PM KST

Revenue by Segment

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
NGS Division
72.17B73.88B76.52B75.99B65.26B
NGS Division Growth
-2.31%-3.45%0.69%16.44%4.33%
Clinical Diagnosis Division
3.14B3.31B2.23B2.67B5.15B
Clinical Diagnosis Division Growth
-5.20%48.60%-16.60%-48.15%28.31%
Others
16.30B11.93B16.19B11.17B8.84B
Others Growth
36.64%-26.31%44.87%26.35%225.14%
CES Division
32.82B33.64B32.81B29.52B26.16B
CES Division Growth
-2.44%2.52%11.15%12.83%4.46%
Genome Application Division
11.35B10.05B10.87B9.82B7.18B
Genome Application Division Growth
12.96%-7.61%10.77%36.69%-15.34%
Total
135.78B132.80B138.62B129.17B112.60B
Total Growth
2.24%-4.19%7.31%14.72%9.52%

Revenue by Geography

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
South Korea
70.96B69.53B70.51B65.22B64.70B
South Korea Growth
2.05%-1.39%8.12%0.81%25.01%
Europe
22.91B22.47B21.49B22.71B16.67B
Europe Growth
1.97%4.54%-5.37%36.23%-
United States of America (USA)
158.21M789.67M474.21M1.22B468.00M
United States of America (USA) Growth
-79.96%66.52%-61.04%160.06%-86.17%
Australia
1.08B992.57M1.44B1.51B1.40B
Australia Growth
8.52%-30.95%-4.72%7.90%-44.58%
Japan
19.59B18.84B21.83B23.12B18.17B
Japan Growth
4.01%-13.71%-5.59%27.26%8.61%
Other
21.08B20.18B22.87B15.39B11.20B
Other Growth
4.43%-11.75%48.57%37.47%-
Total
135.78B132.80B138.62B129.17B112.60B
Total Growth
2.24%-4.19%7.31%14.72%9.52%
Source: S&P Global Market Intelligence.